Select a Country | Site Map | Contact Us
   Diabetes Care
 
 
 
History
 
Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In April 2004, Abbott announced it had completed the acquisition of TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results, Virtually Pain-Free. The TheraSense acquisition strengthened Abbott's position in the large and growing blood glucose monitoring market.